Key takeaways
Farxiga (dapagliflozin) and Afrezza (insulin) are used to manage diabetes, but they have some differences between them. Farxiga is an oral medication that helps lower blood sugar (glucose) in people with Type 2 diabetes by removing extra glucose through the urine. It also helps reduce the risk of heart failure and kidney problems. On the other hand, Afrezza is an inhaled insulin used to quickly lower blood sugar levels around meal times, and can be use in both Type 1 and Type 2 diabetes. Farxiga is taken once daily, while Afrezza is used before meals. Farxiga can cause dehydration and urinary tract infections, while Afrezza can cause low blood sugar and is not safe for people with lung problems like asthma or chronic bronchitis. Both medications are not available as lower-cost generics, but Afrezza offers an alternative for those who prefer not to injection insulin.
